abstract |
The present invention relates to a novel anti-HLA-A2 antibody, and a chimeric antigen receptor comprising said anti-HLA-A2 antibody. The present invention further relates to an immune cell expressing said chimeric antigen receptor, and its therapeutic uses, particularly for the treatment or prevention of transplant rejection or GVHD. |